(Q39545329)

English

Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.

scientific article published on 12 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hong-chiang Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Shyh-Chyan Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

12 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1115-1121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Prostate cancer prevention and finasteride

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Prevention of prostate cancer with finasteride: US/European perspective

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Molecular profiles of finasteride effects on prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Evidence for a biopsy derived grade artifact among larger prostate glands

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Does finasteride alter the pathology of the prostate and cancer grading?

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Update on chemoprevention of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21325

21 January 2018

Identifiers

10.1002/PROS.21325

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21557276%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39545329&oldid=1856236812"